• Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Swedish Orphan Biovitrum AB

+ Add to Watchlist

BIOVF:US

12.4000 USD 0.4500 3.50%

As of 20:10:00 ET on 08/25/2014.

Snapshot for Swedish Orphan Biovitrum AB (BIOVF)

Open: 12.4000 Day's Range: 12.4000 - 12.4000 Volume: 200
Previous Close: 12.8500 52wk Range: 9.9149 - 13.0600 1-Yr Rtn: -

Stock Chart for BIOVF

No chart data available.
  • BIOVF:US 12.4000
  • 1D
  • 1M
  • 1Y
12.8500
Interactive BIOVF Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for BIOVF

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 387.9915
Relative P/E vs. SPX -
Earnings Per Share (SEK) (ttm) -
Est. EPS (SEK) (12/2014) 0.2220
Est. PEG Ratio -
Market Cap (M USD) 3,359.97
Shares Outstanding (M) 270.39
30 Day Average Volume 172
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 10/30/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for BIOVF

  • Revenue
  • Net Income (M/SEK)
  • Profit Margin (%)

Company Profile & Key Executives for BIOVF

Swedish Orphan Biovitrum AB is a biomedical company. The Company develops and makes available orphan drugs and niche specialty pharmaceuticals for patients with rare diseases and with high unmet medical needs.

Geoffrey McDonoughChief Executive OfficerMats-Olof WallinSenior VP/CFO
Alan RaffenspergerSenior VP/COOBirgitte VolckSenior VP/Chief Medical Ofcr
More Company Profile & Key Executives for BIOVF

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil